Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma.
Uchino K, Obi S, Tateishi R, Sato S, Kanda M, Sato T, Arano T, Enooku K, Goto E, Masuzaki R, Nakagawa H, Asaoka Y, Kondo Y, Yamashiki N, Goto T, Shiina S, Omata M, Yoshida H, Koike K.
Uchino K, et al. Among authors: nakagawa h.
J Gastroenterol. 2012 Oct;47(10):1152-9. doi: 10.1007/s00535-012-0574-3. Epub 2012 Mar 22.
J Gastroenterol. 2012.
PMID: 22438097